Published in Women's Health Weekly, February 17th, 2005
Their findings, they say, "show that screening humoral response can identify tumor antigens that may serve as molecular targets in ovarian cancer."
C.I. Vidal and colleagues, explained, "To gain insight into the mechanisms of molecular recognition and humoral immune response in ovarian cancer, we used fingerprinting, a phage display-based combinatorial selection to isolate peptide ligands to tumor-related antibodies present in ascites from patients with advanced...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.